What is LOPJLB’s current signal on NBTX?

LOPJLB’s latest quantitative signal on Nanobiotix S.A. (NBTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is NBTX in?

Nanobiotix S.A. (NBTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Nanobiotix S.A. (NBTX) do?

Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma…